{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:12:24Z","timestamp":1783743144368,"version":"3.55.0"},"reference-count":35,"publisher":"Pharmaceutical Society of Japan","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,7,7]]},"DOI":"10.1248\/bpb.b26-00230","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T22:11:11Z","timestamp":1783375871000},"page":"1060-1066","source":"Crossref","is-referenced-by-count":0,"title":["The Spleen Negatively Regulates the Acute Phase of Experimental Autoimmune Encephalomyelitis in Mice"],"prefix":"10.1248","volume":"49","author":[{"given":"Kyoko","family":"Sawada","sequence":"first","affiliation":[{"name":"Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, 46\u201329 Yoshida-shimoadachi-cho, Sakyo-ku, Kyoto 606\u20138501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunao","family":"Taniyama","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, 46\u201329 Yoshida-shimoadachi-cho, Sakyo-ku, Kyoto 606\u20138501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosei","family":"Tamada","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, 46\u201329 Yoshida-shimoadachi-cho, Sakyo-ku, Kyoto 606\u20138501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Nagayasu","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, 46\u201329 Yoshida-shimoadachi-cho, Sakyo-ku, Kyoto 606\u20138501, Japan"},{"name":"Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, 1\u20136 Yamadaoka, Suita, Osaka 565\u20130871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Shirakawa","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, 46\u201329 Yoshida-shimoadachi-cho, Sakyo-ku, Kyoto 606\u20138501, Japan"},{"name":"Department of Pharmacology, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 4\u201320\u20131 Nasahara, Takatsuki, Osaka 569\u20131094, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Reich DS, Lucchinetti CF, Calabresi PA. Multiple sclerosis. <i>N. Engl. J. Med.<\/i>, <b>378<\/b>, 169\u2013180 (2018).","DOI":"10.1056\/NEJMra1401483"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Charabati M, Wheeler MA, Weiner HL, Quintana FJ. Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting. <i>Cell<\/i>, <b>186<\/b>, 1309\u20131327 (2023).","DOI":"10.1016\/j.cell.2023.03.008"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O. Multiple sclerosis. <i>Lancet<\/i>, <b>391<\/b>, 1622\u20131636 (2018).","DOI":"10.1016\/S0140-6736(18)30481-1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Cree BAC, Oksenberg JR, Hauser SL. Multiple sclerosis: two decades of progress. <i>Lancet Neurol.<\/i>, <b>21<\/b>, 211\u2013214 (2022).","DOI":"10.1016\/S1474-4422(22)00040-0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Healy LM, Stratton JA, Kuhlmann T, Antel J. The role of glial cells in multiple sclerosis disease progression. <i>Nat. Rev. Neurol.<\/i>, <b>18<\/b>, 237\u2013248 (2022).","DOI":"10.1038\/s41582-022-00624-x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Constantinescu CS, Farooqi N, O\u2019Brien K, Gran B. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). <i>Br. J. Pharmacol.<\/i>, <b>164<\/b>, 1079\u20131106 (2011).","DOI":"10.1111\/j.1476-5381.2011.01302.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Ransohoff RM. Animal models of multiple sclerosis: the good, the bad and the bottom line. <i>Nat. Neurosci.<\/i>, <b>15<\/b>, 1074\u20131077 (2012).","DOI":"10.1038\/nn.3168"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Bar-Or A, Li R. Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances. <i>Lancet Neurol.<\/i>, <b>20<\/b>, 470\u2013483 (2021).","DOI":"10.1016\/S1474-4422(21)00063-6"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Mishra MK, Yong VW. Myeloid cells\u2014targets of medication in multiple sclerosis. <i>Nat. Rev. Neurol.<\/i>, <b>12<\/b>, 539\u2013551 (2016).","DOI":"10.1038\/nrneurol.2016.110"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Yates AG, Khamhoung A, Gaebel L, Jacob W, Radford-Smith DE, Kiss MG, Huynh P, Gerhardt T, Heiser M, Cohen O, Swirski FK, Anthony DC, Sumowski J, Katz Sand I, McAlpine CS. Myelopoiesis is temporally dynamic and is regulated by lifestyle to modify multiple sclerosis. <i>Nat. Commun.<\/i>, <b>16<\/b>, 3683 (2025).","DOI":"10.1038\/s41467-025-59074-w"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Lee HG, Wheeler MA, Quintana FJ. Function and therapeutic value of astrocytes in neurological diseases. <i>Nat. Rev. Drug Discov.<\/i>, <b>21<\/b>, 339\u2013358 (2022).","DOI":"10.1038\/s41573-022-00390-x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Lewis SM, Williams A, Eisenbarth SC. Structure and function of the immune system in the spleen. <i>Sci. Immunol.<\/i>, <b>4<\/b>, eaau6085 (2019).","DOI":"10.1126\/sciimmunol.aau6085"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Mebius RE, Kraal G. Structure and function of the spleen. <i>Nat. Rev. Immunol.<\/i>, <b>5<\/b>, 606\u2013616 (2005).","DOI":"10.1038\/nri1669"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Matsui H, Udaka F, Tamura A, Oda M, Kubori T, Nishinaka K, Kameyama M. Multiple sclerosis following splenectomy as a treatment for idiopathic thrombocytopenic purpura. <i>Intern. Med.<\/i>, <b>44<\/b>, 747\u2013749 (2005).","DOI":"10.2169\/internalmedicine.44.747"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Hsu CY, Chen HJ, Hsu CY, Kao CH. Splenectomy increases the subsequent risk of systemic lupus erythematosus. <i>Rheumatol. Int.<\/i>, <b>36<\/b>, 271\u2013276 (2016).","DOI":"10.1007\/s00296-015-3388-9"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Hillis JM, Mateen FJ. Neuromyelitis optica after splenectomy: a secondary autoimmune phenomenon. <i>J. Neuroimmunol.<\/i>, <b>330<\/b>, 152\u2013154 (2019).","DOI":"10.1016\/j.jneuroim.2019.03.008"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Miyamura S, Matsuo N, Nagayasu K, Shirakawa H, Kaneko S. Myelin oligodendrocyte glycoprotein 35-55 (MOG 35-55)-induced experimental autoimmune encephalomyelitis: a model of chronic multiple sclerosis. <i>Bio Protoc.<\/i>, <b>9<\/b>, e3453 (2019).","DOI":"10.21769\/BioProtoc.3453"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) So K, Haraguchi K, Asakura K, Isami K, Sakimoto S, Shirakawa H, Mori Y, Nakagawa T, Kaneko S. Involvement of TRPM2 in a wide range of inflammatory and neuropathic pain mouse models. <i>J. Pharmacol. Sci.<\/i>, <b>127<\/b>, 237\u2013243 (2015).","DOI":"10.1016\/j.jphs.2014.10.003"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Tsutsui M, Hirase R, Miyamura S, Nagayasu K, Nakagawa T, Mori Y, Shirakawa H, Kaneko S. TRPM2 exacerbates central nervous system inflammation in experimental autoimmune encephalomyelitis by increasing production of CXCL2 chemokines. <i>J. Neurosci.<\/i>, <b>38<\/b>, 8484\u20138495 (2018).","DOI":"10.1523\/JNEUROSCI.2203-17.2018"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Tanabe K, Taura K, Koyama Y, Yamamoto G, Nishio T, Okuda Y, Nakamura K, Toriguchi K, Takemoto K, Yamanaka K, Iwaisako K, Seo S, Asagiri M, Hatano E, Uemoto S. Migration of splenic lymphocytes promotes liver fibrosis through modification of T helper cytokine balance in mice. <i>J. Gastroenterol.<\/i>, <b>50<\/b>, 1054\u20131068 (2015).","DOI":"10.1007\/s00535-015-1054-3"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Liu XG, Hou Y, Hou M. How we treat primary immune thrombocytopenia in adults. <i>J. Hematol. Oncol.<\/i>, <b>16<\/b>, 4 (2023).","DOI":"10.1186\/s13045-023-01401-z"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Marzan DE, Br\u00fcgger-Verdon V, West BL, Liddelow S, Samanta J, Salzer JL. Activated microglia drive demyelination <i>via<\/i> CSF1R signaling. <i>Glia<\/i>, <b>69<\/b>, 1583\u20131604 (2021).","DOI":"10.1002\/glia.23980"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Voet S, Mc Guire C, Hagemeyer N, <i>et al<\/i>. A20 critically controls microglia activation and inhibits inflammasome-dependent neuroinflammation. <i>Nat. Commun.<\/i>, <b>9<\/b>, 2036  (2018).","DOI":"10.1038\/s41467-018-04376-5"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Absinta M, Maric D, Gharagozloo M, Garton T, Smith MD, Jin J, Fitzgerald KC, Song A, Liu P, Lin JP, Wu T, Johnson KR, McGavern DB, Schafer DP, Calabresi PA, Reich DS. A lymphocyte-microglia\u2013astrocyte axis in chronic active multiple sclerosis. <i>Nature<\/i>, <b>597<\/b>, 709\u2013714 (2021).","DOI":"10.1038\/s41586-021-03892-7"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Yamasaki R, Lu H, Butovsky O, <i>et al<\/i>. Differential roles of microglia and monocytes in the inflamed central nervous system. <i>J. Exp. Med.<\/i>, <b>211<\/b>, 1533\u20131549 (2014).","DOI":"10.1084\/jem.20132477"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Ajami B, Bennett JL, Krieger C, McNagny KM, Rossi FM. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. <i>Nat. Neurosci.<\/i>, <b>14<\/b>, 1142\u20131149 (2011).","DOI":"10.1038\/nn.2887"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Kim RY, Hoffman AS, Itoh N, Ao Y, Spence R, Sofroniew MV, Voskuhl RR. Astrocyte CCL2 sustains immune cell infiltration in chronic experimental autoimmune encephalomyelitis. <i>J. Neuroimmunol.<\/i>, <b>274<\/b>, 53\u201361 (2014).","DOI":"10.1016\/j.jneuroim.2014.06.009"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Prajeeth CK, L\u00f6hr K, Floess S, Zimmermann J, Ulrich R, Gudi V, Beineke A, Baumg\u00e4rtner W, M\u00fcller M, Huehn J, Stangel M. Effector molecules released by Th1 but not Th17 cells drive an M1 response in microglia. <i>Brain Behav. Immun.<\/i>, <b>37<\/b>, 248\u2013259 (2014).","DOI":"10.1016\/j.bbi.2014.01.001"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Butovsky O, Landa G, Kunis G, Ziv Y, Avidan H, Greenberg N, Schwartz A, Smirnov I, Pollack A, Jung S, Schwartz M. Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. <i>J. Clin. Invest.<\/i>, <b>116<\/b>, 905\u2013915 (2006).","DOI":"10.1172\/JCI26836"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Rodr\u00edguez Mur\u00faa S, Farez MF, Quintana FJ. The immune response in multiple sclerosis. <i>Annu. Rev. Pathol.<\/i>, <b>17<\/b>, 121\u2013139 (2022).","DOI":"10.1146\/annurev-pathol-052920-040318"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Sonanini D, Griessinger CM, Sch\u00f6rg BF, Knopf P, Dittmann K, R\u00f6cken M, Pichler BJ, Kneilling M. Low-dose total body irradiation facilitates antitumoral Th1 immune responses. <i>Theranostics<\/i>, <b>11<\/b>, 7700\u20137714 (2021).","DOI":"10.7150\/thno.61459"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Khanfar E, Olasz K, Gajd\u00f3csi E, Jia X, Berki T, Balogh P, Boldizs\u00e1r F. Splenectomy modulates the immune response but does not prevent joint inflammation in a mouse model of RA. <i>Clin. Exp. Immunol.<\/i>, <b>209<\/b>, 201\u2013214 (2022).","DOI":"10.1093\/cei\/uxac052"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Furtado GC, Marcondes MC, Latkowski JA, Tsai J, Wensky A, Lafaille JJ. Swift entry of myelin-specific T lymphocytes into the central nervous system in spontaneous autoimmune encephalomyelitis. <i>J. Immunol.<\/i>, <b>181<\/b>, 4648\u20134655 (2008).","DOI":"10.4049\/jimmunol.181.7.4648"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Kornberg MD, Smith MD, Shirazi HA, Calabresi PA, Snyder SH, Kim PM. Bryostatin-1 alleviates experimental multiple sclerosis. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>115<\/b>, 2186\u20132191 (2018).","DOI":"10.1073\/pnas.1719902115"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Khanfar E, Olasz K, G\u00e1l S, Gajd\u00f3csi E, Kajt\u00e1r B, Kiss T, Balogh P, Berki T, Boldizs\u00e1r F. Splenectomy at early stage of autoimmune arthritis delayed inflammatory response and reduced joint deterioration in mice. <i>Clin. Exp. Immunol.<\/i>, <b>216<\/b>, 240\u2013251 (2024).","DOI":"10.1093\/cei\/uxae013"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/7\/49_b26-00230\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T03:29:41Z","timestamp":1783740581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/7\/49_b26-00230\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b26-00230","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"article-number":"b26-00230"}}